Correlations of coagulation indexes and inflammatory changes with the prognosis of lung cancer complicated with thromboembolic disease
- PMID: 31128010
Correlations of coagulation indexes and inflammatory changes with the prognosis of lung cancer complicated with thromboembolic disease
Abstract
Purpose: To investigate the correlations of coagulation indexes and inflammatory changes with the prognosis of lung cancer (LC) patients complicated with thromboembolic (TE) disease.
Methods: A total of 84 LC patients complicated with TE disease admitted to hospital from January 2010 to January 2016 were enrolled in this study and their clinical data were retrospectively analyzed. A 2-year post-treatment follow-up was carried out. According to the prognosis, patients were divided into 2 groups as dead group (n=25) and alive group (n=59). The coagulation indexes and inflammatory factor levels before low-molecular weight heparin (LMWH) treatment and on the 1st, 3rd, and 7th day after treatment were compared between the two groups. Their relations with the prognosis of patients were analyzed using Pearson method.
Results: No statistically significant difference was found in the prothrombin time (PT), levels of Fibrinogen (FIB), D-Dimer (D-D), Interleukin-6 (IL-6) and Procalcitonin (PCT), and activated partial thromboplastin time (APTT) before treatment between the two groups (p>0.05). The PT and levels of FIB, D-D, IL-6, and PCT on the 1st, 3rd, and 7th day after treatment were significantly increased in the dead group compared to those in the alive group, while the APTT was remarkably shortened. Moreover, the PT was gradually prolonged and FIB, D-D, IL-6 and PCT levels were increased in the dead group , but the APTT was gradually shortened over time (p<0.05). The poor prognosis of LC patients complicated with TE disease was positively correlated with PT, FIB, D-D, IL-6 and PCT, but negatively correlated with APTT (p<0.05).
Conclusion: The poor prognosis of LC complicated with TE disease has positive correlations with PT, FIB, D-D, IL-6 and PCT, and a negative association with APTT, providing a certain reference as a prognostic value in the diagnosis and treatment.
Similar articles
-
[Analysis of the factors associated with abnormal coagulation and prognosis in patients with non-small cell lung cancer].Zhongguo Fei Ai Za Zhi. 2014 Nov;17(11):789-96. doi: 10.3779/j.issn.1009-3419.2014.11.04. Zhongguo Fei Ai Za Zhi. 2014. PMID: 25404269 Free PMC article. Chinese.
-
Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival.J BUON. 2017 Mar-Apr;22(2):462-467. J BUON. 2017. PMID: 28534370
-
[The changes of blood coagulation in surgical patients with lung cancer].Zhongguo Fei Ai Za Zhi. 2010 Feb;13(2):136-9. doi: 10.3779/j.issn.1009-3419.2010.02.11. Zhongguo Fei Ai Za Zhi. 2010. PMID: 20673507 Free PMC article. Chinese.
-
[A comparative study of the effects of citrate and heparin anticoagulation on coagulation function and efficacy in children with septic shock undergoing continuous blood purification].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023 Aug;35(8):856-859. doi: 10.3760/cma.j.cn121430-20221108-00974. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 37593866 Chinese.
-
[Effect of hydrogen sulfide on tissue factor-induced disseminated intravascular coagulation in rabbits].Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015 Feb;27(2):92-6. doi: 10.3760/cma.j.issn.2095-4352.2015.02.003. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2015. PMID: 25665605 Chinese.
Cited by
-
Prediction of injury localization in preoperative patients with gastrointestinal perforation: a multiomics model analysis.BMC Gastroenterol. 2024 Jan 2;24(1):6. doi: 10.1186/s12876-023-03092-9. BMC Gastroenterol. 2024. PMID: 38166815 Free PMC article.
-
Relationship between Hypercoagulable State and Circulating Tumor Cells in Peripheral Blood, Pathological Characteristics, and Prognosis of Lung Cancer Patients.Evid Based Complement Alternat Med. 2021 Oct 21;2021:5732222. doi: 10.1155/2021/5732222. eCollection 2021. Evid Based Complement Alternat Med. 2021. Retraction in: Evid Based Complement Alternat Med. 2023 Jun 21;2023:9817454. doi: 10.1155/2023/9817454. PMID: 34721635 Free PMC article. Retracted.
-
Golden berry 4β-hydroxywithanolide E prevents tumor necrosis factor α-induced procoagulant activity with enhanced cytotoxicity against human lung cancer cells.Sci Rep. 2021 Feb 25;11(1):4610. doi: 10.1038/s41598-021-84207-8. Sci Rep. 2021. PMID: 33633307 Free PMC article.
-
FDX1 can Impact the Prognosis and Mediate the Metabolism of Lung Adenocarcinoma.Front Pharmacol. 2021 Oct 8;12:749134. doi: 10.3389/fphar.2021.749134. eCollection 2021. Front Pharmacol. 2021. PMID: 34690780 Free PMC article.
-
Prediction of Poor Outcomes in Patients with Colorectal Cancer: Elevated Preoperative Prothrombin Time (PT) and Activated Partial Thromboplastin Time (APTT).Cancer Manag Res. 2020 Jul 3;12:5373-5384. doi: 10.2147/CMAR.S246695. eCollection 2020. Cancer Manag Res. 2020. PMID: 32753955 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical